A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging?
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
A central clinical question as the world deals with the COVID-19 pandemic is what the long-term sequelae for the millions of individuals will be who recover from the hyperinflammatory state characterizing COVID-19 and in particular for the hundreds of thousands who are ill enough to need hospitalization and in particular ICU care. Even when the pandemic is finally controlled, will COVID-19 survivors face exaggerated internal inflammatory processes, worsening co-morbidities, and increased susceptibility to age-related diseases? Clues for what may happen in post-COVID-19 patients can be elicited from those who recovered from other conditions that lead to similar hyperinflammatory states such as Severe Acute Respiratory Syndrome (SARS), acute respiratory disease syndrome (ARDS), cytokine storm syndrome, and post-ICU syndrome. The short-and long-term sequalae following recovery from each of these conditions suggests that these syndromes lead to an accelerated state of chronic subclinical systemic inflammation often seen in aging (termed inflammaging) resulting in increased and worsening age-related conditions including frailty even in younger individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 COVID-19 and Inflammaging. Inflammaging (highlighted in yellow). Systemic, sustained chronic inflammation due to persistent tissue damage, environmental stressors, unhealthy lifestyle, and social and psychological stress is associated with the risk of developing many chronic diseases. Older, obese, and/or smokers with precipitating conditions, are at higher risk. Exogenous compounds such as bacteria or viral fragments including elements of microbiota (pathogen-associated molecular patterns, or PAMPs) or endogenously produced chemical compounds that structurally mimic exogenous compounds (damage-associated molecular patterns or DAMPs) interact with sensors, expressed on the cell surface and in the cytoplasm, to trigger inflammatory responses and pro-inflammatory cytokine secretion (eg. tumor necrosis factor [TNF], interleukin-1 [IL-1], IL-6, and IL-8, and type 1 interferon) that contribute to the state of chronic subclinical systemic inflammation seen in aging (termed inflammaging). Immunobiography, the individual’s history of exposure to certain microorganisms (eg. HIV and CMV) or antigens, may condition the degree and characteristic of the inflammatory response to various stimuli. Inflammaging, which results in an increased incidence and worsening of age-related conditions, is characterized clinically by higher levels of several inflammatory blood biomarkers, including C-reactive protein (CRP), IL-6, IL-18, and TNF. COVID-19 (highlighted in blue). SARS-CoV-2 infection, like SARS-CoV-1 and MERS CoV, can unleash a powerful, and apparently uncontrolled acute inflammatory response in individuals who may be more susceptible because of biological differences in their response to PAMPS, DAMPS, and factors related to immunobiography. Interestingly, prognostic factors for mortality from COVID-19 are similar to those that have been found associated with a high likelihood and prospective risk of chronic inflammation, namely older age, male sex, obesity, smoking, cardiovascular diseases, asthma or other respiratory disease, cancer, autoimmune diseases, multimorbidity, and frailty. This similarity may suggest that the same mechanisms underlying inflammaging are also those that modulate the clinical course of COVID-19 across a wide range of severity, from a mild flu-like syndrome to a severe respiratory failure with high mortality risk. In those with more severe disease, high concentrations of pro-inflammatory mediators, which has been named ‘the cytokine storm,’ affects levels of pro-inflammatory cytokines/chemokines typical of T helper 1 cell response such as IL-6, IFNγ, IP-10, and MCP1. COVID-19 disease severity in hospitalized patients is characterized by severe pneumonia associated with an overt inflammatory reaction typified by high plasma CRP and IL-6, low albumin, high sedimentation rate, low eosinophils, and lymphopenia, often leading to intensive care treatment](https://figures.cochat.ai/paper-figures/292de4d2386749d3a45f5e09f0451c57/a-public-health-perspective-of-aging-do-hyper-inflammatory-syndromes-such-as-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“COVID-19-related VIS may also aggravate age-related pathologies via enhanced SASP-mediated inflammation29,169, as demonstrated for cardiovascular diseases and diabetes in preclinical models170, and might further deteriorate immune competence by inducing senescence in immune cells171,172.”
From COVID-19 and cellular senescence (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hallmarks of immune aging are (a) a state of proinflammatory activation characterized by high circulating levels of proinflammatory cytokines — such as IL-6 and TNF-α — and localized tissue inflammation”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [6]
In the citing paper
“and (b) an aberrant response to antigens and pathogens that could either be blunted, such as in flu vaccination, or excessive, such as in response to SARS-CoV-2 (6).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475 · cited 1×
“Regarding possible COVID-19 treatments that intersect with inflammaging, intriguing results from the RECOVERY (Randomised Evaluation of COVid-19 thERapY) randomized clinical trial of over 11,500 patients in the UK reported that low-dose dexamethasone (6 mg once per day for up to ten days, either by mouth or by intrave…”
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545 · cited 1×
“SARS-CoV-2 mostly affects levels of pro-inflammatory cytokines/chemokines typical of T helper 1 (TH1) cell response such as IL-6, IFNγ, IP-10, and MCP1 [11, 12], that attract monocytes and T cells to the infected site [13, 14], which probably contributes to the lymphopenia and increased neutrophil–lymphocyte ratio see…”
Collaborative, T. O., Williamson, E., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., et al. (2020) · doi:10.1101/2020.05.06.20092999 · Cited by 6,674 · cited 1×
“Interestingly, at least in studies conducted in adult and older COVID-19 patients, prognostic factors for mortality are the same as those found associated with a high likelihood and prospective risk of chronic inflammation, namely older age, male sex, obesity, smoking, cardiovascular diseases, asthma or other respirat…”
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Cited by
Immunology of aging: the birth of inflammaging
Fulop, T., Larbi, A., Pawelec, G., Khalil, A., Cohen, A. A., Hirokawa, K., Witkowski, J. M., & Franceschi, C. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08899-6 · Cited by 464
Self-citationWong, T. L., & Weitzer, D. J. (2021) · Medicina · doi:10.3390/medicina57050418 · Cited by 446
Iqbal, F. M., Lam, K., Sounderajah, V., Clarke, J. M., Ashrafian, H., & Darzi, A. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100899 · Cited by 310
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
Ramakrishnan, R. K., Kashour, T., Hamid, Q., Halwani, R., & Tleyjeh, I. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.686029 · Cited by 235
Connecting aging biology and inflammation in the omics era
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158448 · Cited by 189
Self-citation
Metadata
- Authors
- Bektas, A., Schurman, S. H., Franceschi, C., & Ferrucci, L.
- Affiliations
- National Institutes of Health (US)
- N. I. Lobachevsky State University of Nizhny Novgorod (RU)
- Corresponding author
- Ferrucci, Luigi
- Venue
- Immunity & Ageing
- Published
- 2020-08-24
- Volume
- 17
- Issue
- 1
- Pages
- 23-23
- ISSN
- 1742-4933 (ISSN-L)
- PMC
- PMC7443812
- OpenAlex
- W3080204848
- Cited by
- 102
- References
- 72
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 7 · 2023: 31 · 2022: 23 · 2021: 27 · 2020: 5
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Immunity & Ageing (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute on Aging
- National Institute of Environmental Health Sciences
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- inflammaging, COVID-19 pandemic, SARS, acute respiratory distress syndrome, cytokine storm, post-intensive care syndrome, hyperinflammation, long-term sequelae, frailty, age-related diseases, chronic systemic inflammation, aging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? https://app.cochat.ai/papers/10.1186/s12979-020-00196-8
- The paper
- Bektas, A., Schurman, S. H., Franceschi, C., & Ferrucci, L. (2020). A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immunity & Ageing. https://doi.org/10.1186/s12979-020-00196-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.